Company Landfar Bio-medicine Co., Ltd

Equities

000504

CNE000000263

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Medical & Diagnostic Laboratories

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 29/04/2024 BST			5-day change	1st Jan Change
7.89 ^CNY	+10.04%		+20.27%	-31.98%

04-29	Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.	CI

Landfar Bio medicine Co Ltd is a China-based company mainly engaged in the biomedical and energy conservation & environmental protection business. The Companyâs biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Companyâs energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The Company is involved in other businesses related to aid and build project. The Company mainly conducts businesses within the domestic market.

Number of employees: 512

CNY in Million	2021	Weight	2022	Weight	Delta
Cell Storage and Detection 67.8 %	115	73.2 %	136	67.8 %	+18.60%
Energy-saving Product 24.6 %	30	19.0 %	49	24.6 %	+65.57%
EMC and Engineering Construction 4.1 %	6	3.9 %	8	4.1 %	+34.65%
Biomedical-related Products 3.4 %	6	3.9 %	7	3.4 %	+9.80%
Others 0.1 %	-	-	0	0.1 %	-

CNY in Million	2021	Weight	2022	Weight	Delta
China 69.9 %	122	77.8 %	140	69.9 %	+14.91%
International 30.1 %	35	22.2 %	60	30.1 %	+73.48%

Managers	Title	Age	Since
Chang Qiao You CEO	Chief Executive Officer	51	16/06/20
Peng Bin Lin DFI	Director of Finance/CFO	51	26/01/15
Zhi Fu Li IRC	Investor Relations Contact	-	-
Liang Su SEC	Corporate Secretary	44	10/02/22

Members of the board	Title	Age	Since
Chang Qiao You CEO	Chief Executive Officer	51	16/06/20
Ping Zhao BRD	Director/Board Member	53	28/12/21
Yuan Chen BRD	Director/Board Member	43	29/11/17
Chen Shen BRD	Director/Board Member	37	07/08/18
Yun Yang CHM	Chairman	44	04/01/22
Hai Yi Cao BRD	Director/Board Member	44	28/12/21
Ya Qing Zhao BRD	Director/Board Member	55	08/04/22
Wei Hua Cu BRD	Director/Board Member	45	17/08/18
Jian Qiu CHM	Chairman	52	04/01/22
Feng Yan BRD	Director/Board Member	42	08/03/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	330,023,098	170,384,198 ( 51.63 %)	0	51.63 %

NanHua Bio-medicine Co., Ltd.

3/F, Building B1 Lugu Science & Tech Innovation

410205, Changsha

http://www.landfar.cn

address Landfar Bio-medicine Co., Ltd(000504)

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
LANDFAR BIO-MEDICINE CO., LTD	-31.98%	360M
SONIC HEALTHCARE LIMITED	-18.64%	8.22B
RADNET, INC.	+48.66%	3.73B
SYNLAB AG	-8.06%	2.46B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-38.71%	2.46B
DR. LAL PATHLABS LIMITED	-8.84%	2.36B
NEOGENOMICS, INC.	-9.02%	1.78B
FLEURY S.A.	-19.29%	1.52B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.78%	1.21B
METROPOLIS HEALTHCARE LIMITED	+8.32%	1.12B

Medical & Diagnostic Laboratories